BARRX Medical, Inc. is a privately-held company that develops treatment solutions for Barrett's esophagus, a precancerous condition of the lining of the esophagus caused by gastroesophageal reflux disease. Acquired by Covidien in 2011.
Select Venture Capital & Financial Partners
Alloy VenturesCharter Life SciencesDelphi VenturesFrazier Healthcare VenturesHighland Capital PartnersMontagu Newhall Associates, IncStanford UniversitySutter Hill Ventures